Human-murine chimeric antibodies against respiratory syncytial v

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241421, 4241471, 4241591, 5303873, 53038815, 5303883, A61K 3942, C07K 1608

Patent

active

058243070

ABSTRACT:
This invention relates to a human antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody, against respiratory syncytial virus which is MAb1129 and the use thereof for the prevention and/or treatment of RSV infection.

REFERENCES:
patent: 4659563 (1987-04-01), Dobkin
patent: 4717766 (1988-01-01), Dobkin
patent: 4800078 (1989-01-01), Prince et al.
Tempest et al (1991, Mar.) Biotechnology 9:266-271.
Beeler et al (1989) J. Virol. 63(7):2941-2950.
Jones et al (1986) Nature 329:522-525.
Roitt (1991) "Essential Immunology", Blackwell Scientific Publications, Oxford, pp. 65-68 & 74.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Human-murine chimeric antibodies against respiratory syncytial v does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human-murine chimeric antibodies against respiratory syncytial v, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human-murine chimeric antibodies against respiratory syncytial v will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-241753

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.